# Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging

> **NCT03107325** · PHASE4 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Childhood Neoplasm

## Interventions

- **OTHER:** Modification in acquisition protocol
- **DRUG:** F-18 Fluorodeoxyglucose

## Key facts

- **NCT ID:** NCT03107325
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects who met the study criteria agreed to participate in two years prior to the COVID-19 crisis.
- **Last updated:** 2020-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03107325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03107325, "Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03107325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*